Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Kidney cancer, Lung cancer, Melanoma, Non small cell lung cancer (NSCLC), Renal cell cancer, Secondary cancers, Skin cancer
Closed
Phase 1/2
This study is looking at the safety and usefulness of a new treatment called ImmuniCell that boosts the immune system.
It is open to people with melanoma skin cancer, renal cell kidney cancer or non small cell lung cancer:
that has spread to another part of the body (advanced cancer) or
is slow growing and your doctors thinks this treatment might help
Recruitment start: 1 December 2015
Recruitment end: 27 November 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jeff Evans
TC BioPharm
Last reviewed: 4 December 2018
CRUK internal database number: 14098